IL1B and inflammatory bowel disease: Treatment of IBD patients diagnosed with systemic onset juvenile idiopathic arthritis with IL-1β antagonists showed well-controlled systemic juvenile idiopathic arthritis (sJIA) symptoms at time of diagnosis of IBD [19].